How MDR’s Clinical Investigation Rules Could Drive Some Spinal Fusion Products Out Of EU
Executive Summary
The new EU Medical Device Regulation has introduced stricter clinical evidence requirements for many products. But is it even feasible to generate this data for certain legacy devices, such as those used in spinal fusion surgeries, and which products are likely to fall into the high-risk category?
You may also be interested in...
MDR Up-Classification Of Some Spinal Fusion Devices ‘Unwarranted’ Says Expert Group
A change in risk classification for some legacy spinal fusion devices under the new EU MDR means that certain products face stricter clinical evidence requirements, which expert group OSMA told Medtech Insight is “unnecessary” and “overly-burdensome” for manufacturers.
CAMD Says ‘Critical Appraisal’ Needed On EU MDR Capacity Bottlenecks
Yet another EU regulatory organization has stressed the need for action to address MDR capacity problems. According to CAMD, underlying factors and causes of the crisis must be identified.
Pediatric Cardiologists Told To Prepare For Critical Devices Disappearing Due To MDR
Medical devices used in pediatric heart surgeries and other products used for children and for orphan conditions may cease to be available in the EU due to the new Medical Device Regulation compounding existing market pressures, researchers have warned.